Market Cap | 3.15B | P/E | 15.61 | EPS this Y | 0.90% | Ern Qtrly Grth | -56.10% |
Income | 168.41M | Forward P/E | 12.40 | EPS next Y | 8.60% | 50D Avg Chg | 9.00% |
Sales | 6.53B | PEG | 1.03 | EPS past 5Y | 6.64% | 200D Avg Chg | 17.00% |
Dividend | 3.00% | Price/Book | 2.85 | EPS next 5Y | 9.00% | 52W High Chg | -1.00% |
Recommedations | 2.70 | Quick Ratio | 0.56 | Shares Outstanding | 88.15M | 52W Low Chg | 39.00% |
Insider Own | 1.08% | ROA | 5.60% | Shares Float | 79.80M | Beta | 1.01 |
Inst Own | 89.46% | ROE | 16.28% | Shares Shorted/Prior | 3.45M/3.24M | Price | 33.10 |
Gross Margin | 21.03% | Profit Margin | 2.58% | Avg. Volume | 816,882 | Target Price | 26.44 |
Oper. Margin | 2.13% | Earnings Date | Nov 27 | Volume | 506,034 | Change | 0.06% |
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems. This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, and equipment, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
UBS | Neutral | Sep 5, 24 |
JP Morgan | Neutral | Aug 29, 24 |
B of A Securities | Buy | Aug 29, 24 |
Baird | Neutral | Aug 29, 24 |
Evercore ISI Group | In-Line | Aug 29, 24 |
Evercore ISI Group | In-Line | Jul 9, 24 |
Morgan Stanley | Equal-Weight | Jun 20, 24 |
JP Morgan | Neutral | Jun 20, 24 |
B of A Securities | Buy | May 20, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Zurbay Donald | President & CEO President & CEO | Dec 05 | Sell | 26.58 | 1,868 | 49,651 | 141,923 | 12/07/23 |
BARRY KEVIN MICHAEL | Chief Financial Offi.. Chief Financial Officer | Dec 01 | Sell | 25.36 | 1,627 | 41,261 | 23,103 | 12/04/23 |
ROGAN TIMOTHY E | President - Dental President - Dental | Oct 05 | Sell | 29.7543 | 9,260 | 275,525 | 40,382 | 10/06/23 |
Zurbay Donald | President & CEO President & CEO | Jul 18 | Sell | 32.4828 | 5,620 | 182,553 | 149,539 | 07/19/23 |
KORSH LES B | CLO & Corporate Secr.. CLO & Corporate Secretary | Jul 18 | Sell | 32.4704 | 3,686 | 119,686 | 78,095 | 07/19/23 |
BARRY KEVIN MICHAEL | Chief Financial Offi.. Chief Financial Officer | Dec 05 | Sell | 29.1018 | 9,443 | 274,808 | 6,442 | 12/06/22 |
Zurbay Donald | Chief Financial Offi.. Chief Financial Officer | Jul 06 | Sell | 29.5816 | 10,180 | 301,141 | 78,032 | 07/07/22 |
KORSH LES B | Chief Legal Officer Chief Legal Officer | Jul 06 | Sell | 29.6441 | 4,889 | 144,930 | 71,449 | 07/07/22 |
Frohning Andrea L. | Chief Human Resource.. Chief Human Resources Officer | Jul 06 | Sell | 29.97 | 1,986 | 59,520 | 39,259 | 07/07/22 |
KORSH LES B | Chief Legal Officer Chief Legal Officer | Apr 14 | Sell | 34.9598 | 6,000 | 209,759 | 77,486 | 04/18/22 |
Zurbay Donald | Chief Financial Offi.. Chief Financial Officer | Mar 15 | Sell | 30.8802 | 10,000 | 308,802 | 94,755 | 03/16/22 |
KORSH LES B | VP, General Counsel VP, General Counsel | Mar 15 | Sell | 30.9069 | 6,000 | 185,441 | 83,486 | 03/16/22 |
KORSH LES B | VP, General Counsel VP, General Counsel | Apr 27 | Sell | 33.65 | 1,174 | 39,505 | 101,139 | 04/27/21 |
FERAGEN JODY H | Director Director | Jan 15 | Option | 27.36 | 12,000 | 328,320 | 44,531 | 01/15/21 |
FERAGEN JODY H | Director Director | Jan 15 | Sell | 32.83 | 10,052 | 330,007 | 34,479 | 01/15/21 |